文献速递乳腺MR

基于MRI的影像基因组学分析预测浸润性乳腺癌致癌信号通路基因改变

MRI-based radiogenomics analysis for predicting genetic alterations in oncogenic signalling pathways in invasive breast carcinoma.
PubMed 文献 · Clin Radiol · 2020-03-14

研究纳入88例经活检证实的乳腺癌病例,从T1加权矢状位动态增强MRI提取影像组学特征,构建预测细胞周期、Myc、PI3K、RTK/RAS和p53信号通路基因改变的模型。各通路模型的AUC分别为0.933、0.926、0.956、0.940和0.886,提示基于MRI的影像基因组学分析在预测基因通路改变方面表现优异。

要点

  • 基于MRI的影像组学模型预测乳腺癌细胞周期、Myc、PI3K、RTK/RAS和p53通路改变的AUC为0.886~0.956。
  • 细胞周期影像组学评分与RTK/RAS及p53影像组学评分密切相关。
  • 影像组学特征在不同雌激素受体、孕激素受体和人类表皮生长因子受体2状态患者中呈现失调。

关键影像表现/征象

  • 从基于肿瘤感兴趣区的MRI图像中共获得5234个影像组学特征。
  • 假设检验分别筛选出250、229、156、785和319个在细胞周期、Myc、PI3K、RTK/RAS和p53改变与无改变状态间差异显示的影像组学特征。
  • 根据LASSO算法,分别识别11、12、12、15和13个特征用于构建预测细胞周期、Myc、PI3K、RTK/RAS和p53改变的影像组学标签。
  • 细胞周期影像组学评分与RTK/RAS及p53影像组学评分密切相关。
  • 这些影像组学标签在不同雌激素受体、孕激素受体和人类表皮生长因子受体2状态的患者中亦呈失调。

诊断标准与关键数值

  • 预测细胞周期改变的影像组学标签AUC为0.933。
  • 预测Myc改变的影像组学标签AUC为0.926。
  • 预测PI3K改变的影像组学标签AUC为0.956。
  • 预测RTK/RAS改变的影像组学标签AUC为0.940。
  • 预测p53改变的影像组学标签AUC为0.886。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

AIM: To investigate the effect of radiomics in the assessment of alterations in canonical cancer pathways in breast cancer.

MATERIALS AND METHODS: Eighty-eight biopsy-proven breast cancer cases were included in the present study. Radiomics features were extracted from T1-weighted sagittal dynamic contrast-enhanced magnetic resonance imaging (MRI) images. Radiomics signatures were developed to predict genetic alterations in the cell cycle, Myc, PI3K, RTK/RAS, and p53 signalling pathways by using hypothesis testing combined with least absolute shrinkage and selection operator (LASSO) regression analysis. The predictive powers of the models were examined by the area under the curve (AUC) of the receiver operating characteristic curve.

RESULTS: A total of 5,234 radiomics features were obtained from MRI images based on the tumour region of interest. Hypothesis tests screened 250, 229, 156, 785, and 319 radiomics features that were differentially displayed between cell cycle, Myc, PI3K, RTK/RAS, and p53 alterations and no alteration status. According to the LASSO algorithm, 11, 12, 12, 15, and 13 features were identified for the construction of the radiomics signatures to predict cell cycle, Myc, PI3K, RTK/RAS, and p53 alterations, with AUC values of 0.933, 0.926, 0.956, 0.940, and 0.886, respectively. The cell cycle radiomics score correlated closely with the RTK/RAS and p53 radiomics scores. These signatures were also dysregulated in patients with different oestrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 statuses.

CONCLUSION: MRI-based radiogenomics analysis exhibits excellent performance in predicting genetic pathways alterations, thus providing a novel approach for non-invasively obtaining genetic-level molecular characteristics of tumours.

来源:Clin Radiol,查看原文。版权归原作者所有。

引用

  1. Lin P, Liu WK, Li X, et al. MRI-based radiogenomics analysis for predicting genetic alterations in oncogenic signalling pathways in invasive breast carcinoma. Clin Radiol. 2020. PMID: 32183997. doi:10.1016/j.crad.2020.02.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。